Farmaseutikal: Major
Syarikat-syarikat Mexico utama yang mengeluarkan produk farmaseutikal
Korporasi farmaseutikal global membangunkan dan mengagihkan ubat preskripsi pada skala yang sangat besar. Penamatan paten, kelulusan saluran paip produk (pipeline approvals) dan perundangan penjagaan kesihatan bertindak sebagai pemangkin utama untuk aktiviti dagangan dan kecairan industri. Data pasaran menunjukkan bahawa Genomma Lab Internacional SAB de CV Class B pada masa ini ialah aset bervolum tertinggi, manakala Swedish Orphan Biovitrum AB menduduki tempat teratas dalam senarai pulangan 24 jam. Jadual di bawah menjejak metrik teknikal dan asas yang penting untuk ekuiti-ekuiti ini.
Simbol | Permodalan pasaran | Harga | Perubahan % | Volum | Volum relatif | P/E | EPS cair TTM | Pertumbuhan EPS cair TTM YoY | Hasil dividen % TTM | Sektor | Penarafan penganalisa |
|---|---|---|---|---|---|---|---|---|---|---|---|
 LLYEli Lilly and Company | 24.86 T MXN | 25,456.64 MXN | −3.26% | 64 | 0.20 | 46.24 | 550.53 MXN | +48.52% | 0.47% | Teknologi kesihatan | Beli kuat |
| LLYEli Lilly and Company | 24.86 T MXN | 25,447.94 MXN | −2.01% | 176 | 0.21 | 46.22 | 550.53 MXN | +48.52% | 0.47% | Teknologi kesihatan | Beli kuat |
 JNJJohnson & Johnson | 12.4 T MXN | 5,115.00 MXN | +0.10% | 471 | 0.70 | 42.90 | 119.23 MXN | −37.23% | 1.91% | Teknologi kesihatan | Beli |
| JNJJohnson & Johnson | 12.4 T MXN | 5,115.00 MXN | −0.49% | 60 | 0.56 | 42.90 | 119.23 MXN | −37.23% | 1.91% | Teknologi kesihatan | Beli |
 ABBVAbbVie, Inc. | 9.71 T MXN | 5,420.00 MXN | −1.07% | 155 | 0.80 | 51.57 | 105.09 MXN | +332.56% | 2.35% | Teknologi kesihatan | Beli |
| ABBVAbbVie, Inc. | 9.71 T MXN | 5,386.00 MXN | −3.99% | 94 | 0.46 | 51.25 | 105.09 MXN | +332.56% | 2.35% | Teknologi kesihatan | Beli |
 ROP1/NRoche Holding Ltd | 7.2 T MXN | 8,860.10 MXN | 0.00% | 165 | 1.48 | 26.70 | 331.88 MXN | +19.51% | 2.48% | Teknologi kesihatan | Beli |
 MRKMerck & Co., Inc. | 6.91 T MXN | 2,737.00 MXN | −2.46% | 196 | 0.26 | 154.54 | 17.71 MXN | −87.22% | 2.26% | Teknologi kesihatan | Beli |
| MRKMerck & Co., Inc. | 6.91 T MXN | 2,747.80 MXN | −3.33% | 54 | 0.17 | 155.15 | 17.71 MXN | −87.22% | 2.26% | Teknologi kesihatan | Beli |
 NVS/NNovartis AG Sponsored ADRDR | 5.6 T MXN | 3,016.73 MXN | +0.24% | 1.28 K | 37.35 | 31.85 | 94.70 MXN | −29.57% | 1.87% | Teknologi kesihatan | Beli |
| NOVN/NNovartis AG | 5.6 T MXN | 2,602.21 MXN | 0.00% | 445 | 1.17 | 28.99 | 89.78 MXN | −37.05% | 2.76% | Teknologi kesihatan | Neutral |
 AZN1/NAstraZeneca PLC | 5.46 T MXN | 3,505.21 MXN | +7.85% | 1.27 K | 0.28 | 27.75 | 126.33 MXN | +11.14% | 1.70% | Teknologi kesihatan | Beli |
| AZN1/NAstraZeneca PLC | 5.46 T MXN | 3,518.42 MXN | 0.00% | 111 | 0.09 | 27.85 | 126.33 MXN | +11.14% | 1.70% | Teknologi kesihatan | Beli |
 NOVOB/NNovo Nordisk A/S Class B | 3.53 T MXN | 712.00 MXN | −1.11% | 46 | 0.99 | 10.22 | 69.67 MXN | +4.07% | 4.10% | Teknologi kesihatan | Neutral |
| NOVOB/NNovo Nordisk A/S Class B | 3.53 T MXN | 709.00 MXN | −5.47% | 139 | 0.17 | 10.18 | 69.67 MXN | +4.07% | 4.10% | Teknologi kesihatan | Neutral |
| NVO/NNovo Nordisk A/S Sponsored ADR Class B DR | 3.53 T MXN | 749.80 MXN | −0.69% | 347 | 0.12 | 10.44 | 71.80 MXN | +14.12% | 2.92% | Teknologi kesihatan | Neutral |
 PFEPfizer Inc. | 3.27 T MXN | 549.56 MXN | −2.15% | 1.41 K | 1.34 | 43.46 | 12.65 MXN | −59.79% | 5.59% | Teknologi kesihatan | Neutral |
| PFEPfizer Inc. | 3.27 T MXN | 545.00 MXN | −2.96% | 3.51 K | 0.62 | 43.10 | 12.65 MXN | −59.79% | 5.59% | Teknologi kesihatan | Neutral |
 VRTXVertex Pharmaceuticals Incorporated | 2.59 T MXN | 10,060.63 MXN | 0.00% | 5 | 0.02 | 35.78 | 281.17 MXN | +8.10% | 0.00% | Teknologi kesihatan | Beli |
| VRTXVertex Pharmaceuticals Incorporated | 2.59 T MXN | 9,620.01 MXN | +1.78% | 12 | 0.02 | 34.21 | 281.17 MXN | +8.10% | 0.00% | Teknologi kesihatan | Beli |
 BMYBristol-Myers Squibb Company | 2.45 T MXN | 1,190.00 MXN | −0.01% | 78 | 0.21 | 14.58 | 81.63 MXN | +50.35% | 3.93% | Teknologi kesihatan | Beli |
| BMYBristol-Myers Squibb Company | 2.45 T MXN | 1,190.00 MXN | 0.00% | 1 | 0.01 | 14.58 | 81.63 MXN | +50.35% | 3.93% | Teknologi kesihatan | Beli |
 SNY/NSanofi SA Sponsored ADRDR | 2.11 T MXN | 855.00 MXN | +0.88% | 57 | 0.04 | 25.16 | 33.99 MXN | −35.53% | 3.72% | Teknologi kesihatan | Beli |
| SAN1/NSanofi SA | 2.11 T MXN | 1,532.71 MXN | 0.00% | 2.76 K | 1.03 | 23.03 | 66.55 MXN | −41.74% | 4.90% | Teknologi kesihatan | Beli |
 GSK/NGSK plc Sponsored ADRDR | 1.9 T MXN | 960.00 MXN | +0.95% | 9 | 0.33 | 18.50 | 51.88 MXN | −19.27% | 3.49% | Teknologi kesihatan | Beli |
 REGNRegeneron Pharmaceuticals, Inc. | 1.79 T MXN | 18,330.00 MXN | 0.00% | 1.88 K | 8.12 | 22.37 | 819.27 MXN | +6.99% | 0.40% | Teknologi kesihatan | Beli |
 2359/NWuXi AppTec Co., Ltd. Class H | 1.26 T MXN | 483.34 MXN | +36.11% | 1.11 K | — | 20.81 | 23.23 MXN | +80.11% | 1.21% | Teknologi kesihatan | Beli kuat |
 TAK/NTakeda Pharmaceutical Co. Ltd. Sponsored ADRDR | 1.24 T MXN | 345.00 MXN | +7.81% | 139 | 0.01 | 310.16 | 1.11 MXN | −22.90% | 2.76% | Teknologi kesihatan | Beli |
 UCB/NUCB S.A. | 1.12 T MXN | 1,692.27 MXN | 0.00% | 403 | 0.35 | 7.49 | 226.02 MXN | +49.26% | 0.36% | Teknologi kesihatan | Beli |
 BAYN/NBayer AG | 1.11 T MXN | 953.08 MXN | −4.69% | 202 | 4.96 | — | −35.37 MXN | +54.00% | 0.20% | Teknologi kesihatan | Beli |
 GALD/NGalderma Group AG | 1.03 T MXN | 4,195.64 MXN | +6.05% | 548 | 0.48 | 66.72 | 62.88 MXN | +92.99% | 0.18% | Teknologi kesihatan | Beli |
 HLN/NHaleon PLC | 744.71 B MXN | 99.17 MXN | 0.00% | 1.61 K | 0.09 | 23.59 | 4.20 MXN | −2.34% | 2.16% | Teknologi kesihatan | Beli |
| HLN1/NHaleon PLC Sponsored ADR DR | 744.71 B MXN | 170.00 MXN | −0.58% | 32 | 0.01 | 19.97 | 8.51 MXN | +4.87% | 2.03% | Teknologi kesihatan | Beli |
 RPRX/NRoyalty Pharma Plc Class A | 725.7 B MXN | 1,213.52 MXN | +15.66% | 4.1 K | 0.56 | 43.66 | 27.80 MXN | −13.29% | 1.37% | Teknologi kesihatan | Beli |
 BIIBBiogen Inc. | 700.98 B MXN | 4,722.55 MXN | +9.97% | 3.2 K | 55.17 | 111.78 | 42.25 MXN | −78.98% | 0.00% | Teknologi kesihatan | Beli |
| BIIBBiogen Inc. | 700.98 B MXN | 4,689.60 MXN | 0.00% | 3 | 0.00 | 111.00 | 42.25 MXN | −78.98% | 0.00% | Teknologi kesihatan | Beli |
 ZTSZoetis, Inc. Class A | 686.91 B MXN | 1,623.29 MXN | +5.08% | 324 | 5.65 | 15.26 | 106.40 MXN | −2.40% | 2.38% | Teknologi kesihatan | Neutral |
| ZTSZoetis, Inc. Class A | 686.91 B MXN | 1,550.00 MXN | 0.00% | 1 | 0.02 | 14.57 | 106.40 MXN | −2.40% | 2.38% | Teknologi kesihatan | Neutral |
 INCYIncyte Corporation | 466.66 B MXN | 1,988.32 MXN | 0.00% | 1 | 0.00 | 58.50 | 33.99 MXN | −68.90% | 0.00% | Teknologi kesihatan | Beli |
 INSMInsmed Incorporated | 449.72 B MXN | 1,757.82 MXN | 0.00% | 1 | 0.01 | — | −50.93 MXN | +55.05% | 0.00% | Teknologi kesihatan | Beli kuat |
 VTRSViatris, Inc. | 411.4 B MXN | 364.00 MXN | +20.53% | 158 | 0.02 | — | −6.25 MXN | +88.54% | 2.50% | Teknologi kesihatan | Beli |
| VTRSViatris, Inc. | 411.4 B MXN | 349.02 MXN | +6.28% | 20 | 0.10 | — | −6.25 MXN | +88.54% | 2.50% | Teknologi kesihatan | Beli |
 ALNYAlnylam Pharmaceuticals, Inc | 402.06 B MXN | 4,255.00 MXN | −30.96% | 10 | — | 11.88 | 358.09 MXN | +8,025.55% | 0.00% | Teknologi kesihatan | Beli |
| ALNYAlnylam Pharmaceuticals, Inc | 402.06 B MXN | 5,549.00 MXN | 0.00% | 2 | 0.03 | 15.50 | 358.09 MXN | +8,025.55% | 0.00% | Teknologi kesihatan | Beli |
 SOBI/NSwedish Orphan Biovitrum AB | 317.5 B MXN | 903.50 MXN | +181.40% | 1.92 K | 0.14 | 26.52 | 34.07 MXN | — | 0.00% | Teknologi kesihatan | Beli |
 REC/NRecordati S.p.A. | 229.28 B MXN | 1,109.40 MXN | +8.79% | 2.88 K | 2.36 | 23.32 | 47.58 MXN | +10.59% | 2.52% | Teknologi kesihatan | Neutral |
 IBRXImmunityBio Inc | 176.38 B MXN | 164.00 MXN | — | 40 | — | — | −16.96 MXN | −83.41% | 0.00% | Teknologi kesihatan | Beli kuat |
 ACADACADIA Pharmaceuticals Inc. | 68.94 B MXN | 389.00 MXN | +2.42% | 41 | 0.31 | 10.01 | 38.87 MXN | +55.69% | 0.00% | Teknologi kesihatan | Beli |
 OGNOrganon & Co. | 67.69 B MXN | 255.00 MXN | 0.00% | 2 | 0.04 | 18.34 | 13.90 MXN | −60.58% | 0.58% | Teknologi kesihatan | Neutral |
 ROVI/NLaboratorios Farmaceuticos Rovi, S.A. | 67.45 B MXN | 1,449.78 MXN | +8.82% | 645 | 1.21 | 20.03 | 72.38 MXN | +26.06% | 1.22% | Teknologi kesihatan | Beli |
 PRGO/NPerrigo Co. Plc | 40.94 B MXN | 280.00 MXN | 0.00% | 1 | 0.00 | — | −230.81 MXN | −3,242.42% | 7.33% | Teknologi kesihatan | Neutral |
 SRPTSarepta Therapeutics, Inc. | 37.38 B MXN | 350.00 MXN | 0.00% | 2 | 0.01 | — | −50.72 MXN | −256.41% | 0.00% | Teknologi kesihatan | Neutral |
 HRMYHarmony Biosciences Holdings, Inc. | 37.35 B MXN | 714.50 MXN | +1.93% | 500 | — | 13.05 | 54.75 MXN | −5.94% | 0.00% | Teknologi kesihatan | Beli |
 RAREUltragenyx Pharmaceutical, Inc. | 31.53 B MXN | 256.00 MXN | −7.56% | 250 | — | — | −93.85 MXN | +13.80% | 0.00% | Teknologi kesihatan | Beli |
 LAB/BGenomma Lab Internacional SAB de CV Class B | 15.49 B MXN | 15.94 MXN | +5.56% | 3.72 M | 0.79 | 9.12 | 1.75 MXN | −3.07% | 5.16% | Teknologi kesihatan | Beli |
| LAB/BGenomma Lab Internacional SAB de CV Class B | 15.49 B MXN | 16.00 MXN | +5.82% | 273.52 K | 0.95 | 9.16 | 1.75 MXN | −3.07% | 5.16% | Teknologi kesihatan | Beli |
 OCGNOcugen Inc | 5.53 B MXN | 16.90 MXN | +5.62% | 4.29 K | 2.31 | — | −3.60 MXN | +9.26% | 0.00% | Teknologi kesihatan | Beli kuat |
| OCGNOcugen Inc | 5.53 B MXN | 16.42 MXN | −0.48% | 3.82 K | 13.03 | — | −3.60 MXN | +9.26% | 0.00% | Teknologi kesihatan | Beli kuat |
 INOInovio Pharmaceuticals, Inc. | 3.12 B MXN | 27.40 MXN | −8.79% | 2.04 K | 6.88 | — | −20.58 MXN | +57.91% | 0.00% | Teknologi kesihatan | Beli kuat |
| INOInovio Pharmaceuticals, Inc. | 3.12 B MXN | 22.00 MXN | −19.71% | 9.69 K | 7.09 | — | −20.58 MXN | +57.91% | 0.00% | Teknologi kesihatan | Beli kuat |
 ATOSAtossa Therapeutics, Inc. | 394.26 M MXN | 36.50 MXN | −13.10% | 114 | 0.78 | — | −76.05 MXN | −20.21% | 0.00% | Teknologi kesihatan | Beli kuat |
| ATOSAtossa Therapeutics, Inc. | 394.26 M MXN | 38.01 MXN | −15.53% | 5 | 0.04 | — | −76.05 MXN | −20.21% | 0.00% | Teknologi kesihatan | Beli kuat |